Table 1.
Compound | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Fluconazole | Caspofungin |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series | Tri-aryl | Bis-amide | Tri-cyclic | Tri-cyclic | Bis-amide | Bis-amide | Bi-aryl | Bis-amide | Bis-amide | Bi-aryl | Bi-aryl | ||
Activity against C. albicans (μg/mL) | |||||||||||||
MIC | 4 | 4 | 2 | 4 | 4 | 4 | 4 | 8 | >8 | 0.3 | 8 | 0.25 | 0.25 |
MFC | 8 | 16 | 8 | 8 | 8 | 8 | 8 | 16 | >8 | 0.78 | ND | 0.5 | |
MIC+50% Human serum | 4 | 4 | 16 | 4 | 16 | 16 | 16 | 32 | >8 | ND | >8 | ||
NAC species MIC (μg/mL) | |||||||||||||
C. tropicalis | 4–8 | 8 | 4 | 2–4 | 2 | 4 | 8 | 4 | 2 | ND | 1 | ||
C. parapsilosis | 4–8 | 1 | 1 | 2 | 1 | 2 | 2 | 4 | 0.5 | ND | 0.25 | ||
C. dublinensis | 8 | 32 | 16 | 4 | 2 | 2 | 4 | 4 | ND | ND | ND | ||
C. glabrata | 4 | 8 | 2 | 2 | 4 | 4 | 4 | 8 | >8 | ND | 1 | ||
C. krusei | 32 | 8 | 0.50 | 16 | 2 | 2 | 4 | 4 | 1 | ND | 4 |
ND, not determined.